⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of TenNor Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
TenNor Therapeutics
↗Suzhou, China
TenNor Therapeutics is a near-commercial stage biotechnology company founded in 2013, dedicated to the discovery, development, and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism. The company utilizes a proprietary multi-targeting conjugate molecule technology platform to address unmet medical needs and overcome the limitations of conventional treatments.
Headquartered in Suzhou Industrial Park, China, TenNor has built a robust pipeline of innovative programs. The company focuses on indications such as Helicobacter pylori infection, prosthetic joint infections, hepatic encephalopathy, and other bacterial-related conditions. It is recognized for its international R&D team and global intellectual property protection strategy.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Infectious Disease / Antibacterials
SIZE & FINANCIALS
Employees:51-200
Founded:2013
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$109M
Investors:AMR Action Fund, Zhongshantoukong, NLVC, Oriza Holdings, Frontline BioVentures
STOCK
Exchange:HKEX
Ticker:6872
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Small molecule, Multi-targeting drug conjugates
Trial Phases:Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Peking University First Hospital (Clinical collaboration), Wuxi New Drug Development (Cooperation)
COMPETITION
Position:Emerging
Competitors:Spero Therapeutics, Vedanta Biosciences, Locus Biosciences
LEADERSHIP
Key Executives:
Zhenkun Ma - CEO
LINKS
Website:tennorx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TenNor Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.